查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1520407

2024-2032 年按类型、应用、最终用户和地区分類的血浆衍生物市场报告

Blood Plasma Derivatives Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年，全球血浆衍生性商品IMARC Group规模达458亿美元。

血浆衍生物是透过分馏过程获得的血浆製备的特定蛋白质的浓缩物。因子 VIII、免疫球蛋白、白蛋白、超免疫球蛋白、因子 IX 和新鲜冷冻血浆是一些常见的血浆衍生物。它们富含蛋白质、矿物质、盐、激素、维生素和蛋白酶抑制剂，因此被广泛用于杀死导致B型肝炎、甲型血友病、出血性疾病、免疫缺陷、丙型肝炎、低丙种球蛋白血症、B型血友病和人类免疫缺陷的病毒病毒（爱滋病毒）。除此之外，血浆衍生物有助于增强营养、控制体温和凝血、维持渗透压、增强呼吸和排泄、调节酸碱平衡。血浆衍生物通常储存在医院、诊所、诊断中心和输血中心。

血浆衍生性商品市场趋势：

越来越多的老年人口更容易患传染病，这为市场创造了积极的前景。血浆中含有免疫球蛋白，在免疫发展和维持血管渗透压方面发挥重要作用，从而进一步预防免疫缺陷病和血友病的发生。此外，透过恢復期血浆治疗治疗冠状病毒疾病（COVID-19）患者的产品的广泛采用有利于市场成长。此外，分馏过程中的各种技术创新有助于分离临床用途的浓缩蛋白和血浆的各种成分，这极大地促进了市场成长。与此一致的是，先进保存方法的开发，以及开发标靶治疗产品的封装程序的显着改进，正在进一步促进市场成长。其他因素，包括医疗保健行业的显着增长、人们对血液和血浆捐赠的认识不断提高以及政府实施各种促进捐血营的倡议，预计将推动市场进一步增长。

本报告回答的关键问题

  • 2023年全球血浆衍生性商品市场规模有多大？
  • 2024-2032年全球血浆衍生性商品市场的预期成长率是多少？
  • 推动全球血浆衍生性商品市场的关键因素是什么？
  • COVID-19对全球血浆衍生性商品市场有何影响？
  • 全球血浆衍生物市场按类型划分是怎样的？
  • 基于最终用户的全球血浆衍生性商品市场的细分情况如何？
  • 全球血浆衍生性商品市场的重点区域有哪些？
  • 全球血浆衍生性商品市场的主要参与者/公司有哪些？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球血浆衍生性商品市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 白蛋白
    • 市场走向
    • 市场预测
  • 因子VIII
    • 市场走向
    • 市场预测
  • 因子IX
    • 市场走向
    • 市场预测
  • 免疫球蛋白
    • 市场走向
    • 市场预测
  • 超免疫球蛋白
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：按应用

  • 血友病
    • 市场走向
    • 市场预测
  • 低丙种球蛋白血症
    • 市场走向
    • 市场预测
  • 免疫缺乏疾病
    • 市场走向
    • 市场预测
  • 血管性血友病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 医院
    • 市场走向
    • 市场预测
  • 诊所
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols SA
    • Kedrion SpA
    • LFB SA
    • Octapharma AG
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112024A5371

The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Albumin

Factor VIII

Factor IX

Immunoglobulin

Hyperimmune Globulin

Others

Breakup by Application:

Hemophilia

Hypogammaglobulinemia

Immunodeficiency Diseases

Von Willebrand's Disease

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global blood plasma derivatives market in 2023?
  • 2. What is the expected growth rate of the global blood plasma derivatives market during 2024-2032?
  • 3. What are the key factors driving the global blood plasma derivatives market?
  • 4. What has been the impact of COVID-19 on the global blood plasma derivatives market?
  • 5. What is the breakup of the global blood plasma derivatives market based on the type?
  • 6. What is the breakup of the global blood plasma derivatives market based on the end-user?
  • 7. What are the key regions in the global blood plasma derivatives market?
  • 8. Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players